March 6, 2013
Avion Pharmaceuticals, a specialty pharmaceutical company, announces their participation as an exhibitor at the annual American Academy of Dermatology Meeting. The meeting was held at the Miami Beach Convention Center from March 1-5th, 2013.
For Avion Pharmaceuticals, the sponsorship of the exhibition at the AAD represents an important milestone for the company. This is the first appearance for Avion Pharmaceuticals at the annual Dermatology conference and demonstrates Avion’ commitment to support for the Dermatology category with a product that provides a unique alternative to help manage acne using an easy- to- take natural supplement.
“Avion is a pleased to introduce our company to the Dermatology community and excited to support the efforts of the American Academy of Dermatology”, stated Mike Sullivan, Vice President of Sales and Marketing for Avion Pharmaceuticals. “We are looking forward to sharing the benefits of Nicomide® for inflammatory acne and very excited to bring new and innovative product solutions to the Dermatology community.”
CEO Mark Pugh added, “The American Academy of Dermatology is truly a dynamic organization with passionate and informed members. Avion Pharmaceuticals is looking forward to interacting with AAD members, prescribers and others attending this annual meeting and sharing new and helpful information that will benefit acne patients”.
About Avion Pharmaceuticals, LLC
Avion Pharmaceuticals, LLC., is a Specialty Pharmaceutical company formed to develop and market a portfolio of innovative pharmaceutical products in the Women’s Heath and Dermatology therapeutic areas. Avion Pharmaceuticals focuses on identifying opportunities to acquire and enhance the market potential of innovative, commercially available therapeutics and late-stage development drugs to fulfill unmet medical needs. For additional information about Avion Pharmaceuticals please contact the company at 678-325-5188.